Paul Mellett
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Paul J.
Mellett formerly worked at TAS-CNH, Inc., as Director, GelTex Pharmaceuticals, Inc., as Chief Financial Officer & VP-Administration from 1997 to 2000, Essential Therapeutics, Inc., as Chief Financial Officer & Senior Vice President from 2001 to 2003, Deloitte & Touche LLP, as Audit Partner from 1977 to 1994, Marshall Contractors, Inc., as Chief Financial Officer from 1994 to 1997, and Enanta Pharmaceuticals, Inc., as Chief Financial & Administrative Officer from 2024 to 2025.
Mr. Mellett received his undergraduate degree in 1977 from Boston College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.02.2025 | 95’884 ( 0.33% ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
TAS-CNH, Inc.
TAS-CNH, Inc. Services to the Health IndustryHealth Services Provides emergency medical and transport services | Direktor/Vorstandsmitglied | 03.09.2025 |
| ENANTA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 26.08.2025 |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections | Finanzdirektor/CFO | 01.08.2003 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Finanzdirektor/CFO | 01.12.2000 |
Marshall Contractors, Inc.
Marshall Contractors, Inc. Engineering & ConstructionIndustrial Services Contractor specializing in electronic centers and buildings | Finanzdirektor/CFO | 01.01.1997 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Marshall Contractors, Inc.
Marshall Contractors, Inc. Engineering & ConstructionIndustrial Services Contractor specializing in electronic centers and buildings | Industrial Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
TAS-CNH, Inc.
TAS-CNH, Inc. Services to the Health IndustryHealth Services Provides emergency medical and transport services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen